BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27938583)

  • 1. [Meta-analysis: somatostatin for prophylaxis against post endoscopic retrograde cholangiopancreatography pancreatitis].
    Pan SB; Geng XP
    Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):466-472. PubMed ID: 27938583
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis.
    Omata F; Deshpande G; Tokuda Y; Takahashi O; Ohde S; Carr-Locke DL; Jacobs JL; Mine T; Fukui T
    J Gastroenterol; 2010 Aug; 45(8):885-95. PubMed ID: 20373114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis.
    Qin X; Lei WS; Xing ZX; Shi F
    Saudi J Gastroenterol; 2015; 21(6):372-8. PubMed ID: 26655132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
    Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.
    Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.
    Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST
    Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
    Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
    Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.
    Andriulli A; Leandro G; Federici T; Ippolito A; Forlano R; Iacobellis A; Annese V
    Gastrointest Endosc; 2007 Apr; 65(4):624-32. PubMed ID: 17383459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a controlled, non-randomized study].
    Vila JJ; Jiménez FJ; Prieto C; Borobio E; Juanmartiñena JF; Borda F
    Gastroenterol Hepatol; 2006 Apr; 29(4):231-6. PubMed ID: 16584693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
    Andriulli A; Clemente R; Solmi L; Terruzzi V; Suriani R; Sigillito A; Leandro G; Leo P; De Maio G; Perri F
    Gastrointest Endosc; 2002 Oct; 56(4):488-95. PubMed ID: 12297762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials.
    Rudin D; Kiss A; Wetz RV; Sottile VM
    J Gastroenterol Hepatol; 2007 Jul; 22(7):977-83. PubMed ID: 17559376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.
    Andriulli A; Leandro G; Niro G; Mangia A; Festa V; Gambassi G; Villani MR; Facciorusso D; Conoscitore P; Spirito F; De Maio G
    Gastrointest Endosc; 2000 Jan; 51(1):1-7. PubMed ID: 10625786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
    Andriulli A; Solmi L; Loperfido S; Leo P; Festa V; Belmonte A; Spirito F; Silla M; Forte G; Terruzzi V; Marenco G; Ciliberto E; Sabatino A; Monica F; Magnolia MR; Perri F
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study.
    Bordas JM; Toledo-Pimentel V; Llach J; Elena M; Mondelo F; Ginès A; Terés J
    Gastrointest Endosc; 1998 Mar; 47(3):230-4. PubMed ID: 9540874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial.
    Bai Y; Ren X; Zhang XF; Lv NH; Guo XG; Wan XJ; Nie ZG; Han ST; Bie P; Tian DA; Ji M; Li ZS
    Endoscopy; 2015 May; 47(5):415-20. PubMed ID: 25590178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial.
    Arvanitidis D; Anagnostopoulos GK; Giannopoulos D; Pantes A; Agaritsi R; Margantinis G; Tsiakos S; Sakorafas G; Kostopoulos P
    J Gastroenterol Hepatol; 2004 Mar; 19(3):278-82. PubMed ID: 14748874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.